(Q39443708)
Statements
1 reference
Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States (English)
1 reference
Min Huang
1 reference
Yanyan Lou
1 reference
James Pellissier
1 reference
Thomas Burke
1 reference
Frank Xiaoqing Liu
1 reference
Ruifeng Xu
1 reference
Vamsidhar Velcheti
1 reference
29 August 2016
1 reference
1 reference
20
1 reference
2
1 reference
140-150
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference